Fujifilm Holdings Corp. (OTCMKTS:FUJIY) Stock Short Interest Jumps 396.3%

Fujifilm Holdings Corp. (OTCMKTS:FUJIY) was the recipient of a significant growth in short interest in September. As of September 30th, there was short interest totaling 183,494 shares, a growth of 396.3% from the September 15th total of 36,976 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average trading volume of 296,018 shares, the short-interest ratio is currently 0.6 days.

Fujifilm Price Performance

Shares of FUJIY stock opened at $10.81 on Friday. The firm has a fifty day moving average of $10.54 and a two-hundred day moving average of $10.38. The firm has a market cap of $26.89 billion, a P/E ratio of 8.51, a P/E/G ratio of 1.29 and a beta of 0.69. Fujifilm has a 1-year low of $8.93 and a 1-year high of $12.18. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.37 and a quick ratio of 0.84.

Fujifilm (OTCMKTS:FUJIY) last issued its earnings results on Thursday, August 6th. The technology company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.06). Fujifilm had a net margin of 7.61% and a return on equity of 6.91%. The company had revenue of $5.25 billion during the quarter, compared to analyst estimates of $4.97 billion. Fujifilm has set its FY 2026 guidance at 0.735-0.735 EPS. As a group, research analysts anticipate that Fujifilm will post 0.75 earnings per share for the current fiscal year.

About Fujifilm

Fujifilm Holdings Corporation, through its subsidiaries, develops and markets imaging, healthcare, business, and advanced technology products and services. The company traces its origins to Fuji Photo Film Co, Ltd., established in Japan in 1934 to manufacture photographic film. Over time, Fujifilm diversified beyond photographic materials as demand for traditional film declined.

Its healthcare activities include medical imaging systems, endoscopy equipment, in-vitro diagnostics, biopharmaceutical contract development and manufacturing, and life sciences products.